MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/02841860902719174

Медицинская библиотека · Acta oncologica (Stockholm, Sweden) · 2009

Prostate cancer treatment in Europe at the end of 1990s.

Gatta Gemma, Zigon Giulia, Buemi Antoine, Coebergh Jan Willem, Colonna Marc, Contiero Paolo, Denis Louis, Grosclaude Pascale, Guizard Ann Valèrie, Sanchez-Perez Maria Jose, Plesko Ivan, Ondrusova Martina, Rachtan Jadwiga, Valdagni Riccardo, Velten Michael, Vercelli Marina, Berrino Franco

СтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

There is wide variation in prostate cancer incidence and survival across Europe. In many countries incidence is rising sharply in relation to the introduction of prostate-specific antigen assay, and there is concern that patients may not be treated appropriately. We therefore aimed to characterize treatment for prostate cancer across Europe.

METHODS

We performed a high resolution population-based study, collecting information on the treatment of 3 486 prostate cancer cases diagnosed in 1995-1999 in 11 cancer registries from six European countries.

RESULTS

Overall, about one in three patients received radical treatment (prostatectomy 23% or radiotherapy 14%); about 60% of younger patients (<70 years) received radical treatment, while a similar proportion of older patients (> or =70 years) received palliation (transurethral prostatectomy or hormone treatment only). A considerable proportion (61%) of patients with apparently high-risk disease were treated radically within a year of diagnosis, with large variation between regions: >70% in Calvados, Haut-Rhin, Tarn and Eindhoven and <50% in Slovakia and Cracow. Overall 34% of patients with apparently low-risk disease received radical treatment, varying from 17% and 22% in Bas-Rhin and Granada, to 52% and 56% in Calvados and Eindhoven.

CONCLUSIONS

Our data indicate wide variation in the treatment for prostate cancer even among patients with apparently similar disease, and further suggest a non-negligible proportion may be receiving inappropriate radical treatment for apparently low-risk disease. Current guidelines indicate active surveillance should become the main means of managing low-risk disease.

Для цитирования: Gatta Gemma, Zigon Giulia, Buemi Antoine, Coebergh Jan Willem, Colonna Marc, Contiero Paolo, Denis Louis, Grosclaude Pascale, Guizard Ann Valèrie, Sanchez-Perez Maria Jose, Plesko Ivan, Ondrusova Martina, Rachtan Jadwiga, Valdagni Riccardo, Velten Michael, Vercelli Marina, Berrino Franco. Prostate cancer treatment in Europe at the end of 1990s.. Acta oncologica (Stockholm, Sweden). 2009. DOI: 10.1080/02841860902719174.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.